103339-87-3

Upstream product

• 31972-52-8 Boc-Gly-Gly-OH 
• 70-11-1 α-bromoacetophenone 
• 4530-20-5 BOC-glycine 
• 83316-95-4 2-oxo-2-phenylethyl 2-(tert-butoxycarbonylamino)acetate 

Downstream Products

• 129279-96-5 Boc-^DPen(MBzl)-Phe-Gly-Gly-OPac 
• 129279-95-4 Boc-Pen(MBzl)-Phe-Gly-Gly-OPac 
• 103339-89-5 Boc-Cys(MeBzl)-Phe-Gly-Gly-OPac 
• 129279-94-3 Boc-^DCys(MeBzl)-Phe-Gly-Gly-OPac 
• 103339-88-4 Boc-Phe-Gly-Gly-OPac 
• 106657-01-6 Boc-Gly-Gly-Pro-Gly-Ala-Gly-OPac 
• 763121-17-1 phenacyl [N-(1-naphthylacetyl)glycyl]glycinate 
• 763121-16-0 phenacyl [N-(phenylacetyl)glycyl]glycinate 
• 31972-52-8 Boc-Gly-Gly-OH 

Relevant academic research and scientific papers

An efficient method for the synthesis of phenacyl ester-protected dipeptides using neutral alumina-supported sodium carbonate 'Na2CO3/n-Al2O3'

In the synthesis of dipeptides (Boc-AA1-AA2-OPac: AA1 and AA2 represent amino acids) protected by phenacyl (Pac) ester, amines and solid bases as the base for the conversion of the trifluoroacetic acid (TFA) sal

Intramolecular triplet-triplet energy transfer in short flexible bichromophoric amino acids, dipeptides and carboxylic acid diester

Efficiencies of the intramolecular triplet-triplet energy transfer (ITET) in various bichromophoric amino acids (glycine, valine, phenylalanine, and sarcosine), dipeptides (glycylglycine, phenylalanylphenylalanine), and a simple diester, with the benzoyl

Design of the Synthetic Route for Peptides and Proteins Based on the Solubility Prediction Method. I. Synthesis and Solubility Properties of Human Proinsulin C-Peptide Fragments

The usefulness of the solubility prediction method is demonstrated using relatively small peptide fragments of human proinsulin C-peptide.The propriety of the solubility prediction method for peptides having polar side chains is also examined in the following respects: (1) Peptide intermediates smaller than a heptapeptide have high solubility regardless of their c> values; (2) the c> values of peptide intermediates are useful for judging solubility of peptide intermediates equal to or larger than an octapeptide level; (3) the Pro residue in a central position of a peptide chain is effective for increasing peptide solubility; and (4) there is critical chain length for peptide insolubility caused by a β-sheet aggregation.A strategy suitable for the design of the synthetic route or human proinsulin C-peptide is subsequently discussed on the basis of the solubility prediction of peptide intermediates.